Amylyx Pharmaceuticals, Inc.
AMLX
Classement en actions
#4500
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Prix de l'action
$27.25
Capitalisation boursière
$3.42B
Changement (1 jour)
3.45%
Changement (1 an)
82.27%
Pays
US
Échange Amylyx Pharmaceuticals, Inc. (AMLX)
Catégorie
Healthcare
Historique des dividendes pour Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (symbole boursier : AMLX) a versé un total de 3 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $1.02
Rendement du dividende (TTM) : 0
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $1.02
Rendement du dividende (TTM) : 0
Versements de dividendes pour Amylyx Pharmaceuticals, Inc. (AMLX) de 2017 à 2026
Versements annuels de dividendes
| Année | Dividende (ajusté pour divisions d’actions) | Changez |
|---|---|---|
| 2026 (TTM) | $0.42 | 0.00% |
| 2018 | $0.42 | -30.00% |
| 2017 | $0.6 | 0.00% |
Liste de tous les paiements de dividendes
| Année | Dividende | Changez |
|---|---|---|
| 2026 (TTM) | $0.42 | 0.00% |
| 2018 | $0.42 | -30.00% |
| 2017 | $0.6 | 0.00% |
Dividendes versés par des entreprises similaires ou concurrentes
| Entreprise | Nombre de paiements de dividendes | Pays |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
